• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在战时,确定患有轻度 COVID-19 的患者在急性和新冠后时期的躯体、神经和心理-情绪表现。

DETERMINATION OF SOMATIC, NEUROLOGICAL AND PSYCHO-EMOTIONAL MANIFESTATIONS OF THE ACUTE AND POSTCOVID PERIOD IN PATIENTS WITH A MILD COURSE OF COVID-19 IN WARTIME.

机构信息

EDUCATIONAL AND SCIENTIFIC MEDICAL INSTITUTE OF THE NATIONAL TECHNICAL UNIVERSITY «KHARKIV POLYTECHNIC INSTITUTE», KHARKIV, UKRAINE.

出版信息

Wiad Lek. 2023;76(5 pt 2):1160-1166. doi: 10.36740/WLek202305204.

DOI:10.36740/WLek202305204
PMID:37364067
Abstract

OBJECTIVE

The aim: To analyze the typical symptom complex at the stage of COVID-19 acute phase in the systemic relationship with somatic, psychosomatic, and neurological manifestations.

PATIENTS AND METHODS

Materials and methods: The collection of primary material was performed by clinical-anamnestic method, laboratory, and sociological examination of patients treated out patiently. Summarizing of the results was performed according to the analysis of 100 completed cases of COVID-19 in patients aged 35-45 years (50 men and 50 women) who had no concomitant chronic pathology, and patients did not receive any vaccine dose before the disease (acute COVID-19) and during the next follow-up period (6 months).

RESULTS

Results: The data of the analysis allowed us to make a grounded conclusion about the syndromic heterogeneity of COVID 19 in a standardized patients group with a mild course.

CONCLUSION

Conclusions: the highest number of symptoms in the postcovid period by frequency, polymorphism, and life quality impact was found in the group of patients with subjectively tolerate acute COVID-19 most easily. Patients whose acute episode meets the mild criteria have pronounced neurological and psychoemotional manifestations during the postcovid period.

摘要

目的

分析 COVID-19 急性期的典型症状与躯体、身心和神经表现之间的系统关系。

患者和方法

材料和方法:通过临床病史法、实验室和对接受姑息治疗的患者进行社会学检查收集原始资料。根据对 100 例年龄在 35-45 岁之间(50 名男性和 50 名女性)、无合并慢性病史且在疾病(急性 COVID-19)前和下一个随访期(6 个月)期间未接受任何疫苗剂量的患者的 COVID-19 进行的分析,总结结果。

结果

结果:分析数据使我们能够对标准化患者组中轻度病程的 COVID 19 的综合征异质性做出合理的结论。

结论

结论:在主观上最容易耐受急性 COVID-19 的患者组中,在后 COVID 期出现的症状数量最多,频率最高、表现形式最多样、对生活质量的影响最大。在急性发作符合轻度标准的患者中,在后 COVID 期出现明显的神经和心理情绪表现。

相似文献

1
DETERMINATION OF SOMATIC, NEUROLOGICAL AND PSYCHO-EMOTIONAL MANIFESTATIONS OF THE ACUTE AND POSTCOVID PERIOD IN PATIENTS WITH A MILD COURSE OF COVID-19 IN WARTIME.在战时,确定患有轻度 COVID-19 的患者在急性和新冠后时期的躯体、神经和心理-情绪表现。
Wiad Lek. 2023;76(5 pt 2):1160-1166. doi: 10.36740/WLek202305204.
2
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
3
[The result of prospective randomized study CITADEL - the efficacy and safety of drug cytoflavin in postcovid rehabilitation].[前瞻性随机研究CITADAL的结果——细胞黄素在新冠康复中的疗效和安全性]
Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(10):45-51. doi: 10.17116/jnevro202112110145.
4
[Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX].[新冠后综合征患病率的测定及药物Cortexin治疗新冠后综合征患者神经障碍有效性的评估。多中心临床和流行病学观察项目CORTEX的结果]
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(1):84-90. doi: 10.17116/jnevro202212201184.
5
[Neurological disorders in the postcovid period].[新冠疫情后时期的神经系统疾病]
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(10):31-37. doi: 10.17116/jnevro202212210131.
6
Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program.新冠后综合征患病率的测定及药物皮质素治疗新冠后综合征患者神经障碍的有效性评估。CORTEX多中心临床与流行病学观察项目的结果
Neurosci Behav Physiol. 2022;52(6):836-841. doi: 10.1007/s11055-022-01307-2. Epub 2022 Oct 26.
7
Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.伊维菌素预防 COVID-19 患者住院(IVERCOR-COVID19):一项随机对照试验的研究方案的结构化总结。
Trials. 2020 Nov 24;21(1):965. doi: 10.1186/s13063-020-04813-1.
8
[Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].[创伤后应激障碍(PTSD)作为个体遗传易感性、创伤性事件和社会环境之间相互作用的结果]
Encephale. 2012 Oct;38(5):373-80. doi: 10.1016/j.encep.2011.12.003. Epub 2012 Jan 24.
9
Emotional and psychological impact of infection and postCOVID-19 in older people: beyond the usual symptoms of long COVID.感染及新冠后对老年人的情绪和心理影响:超越长期新冠的常见症状
Eur Geriatr Med. 2022 Jun;13(3):693-694. doi: 10.1007/s41999-022-00634-4.
10
Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study.新冠病毒感染 1 年后的神经系统结局:一项前瞻性纵向队列研究。
Eur J Neurol. 2022 Jun;29(6):1685-1696. doi: 10.1111/ene.15307. Epub 2022 Mar 23.